表紙
市場調查報告書

消化管支架市場分析:產品(膽管、十二指腸、大腸、胰管、食道支架)、用途(肝疾病、大腸癌、胃癌)、各地區的預測

Gastrointestinal (GI) Stents Market Analysis By Product (Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents), By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 557265
出版日期 內容資訊 英文 90 Pages
商品交期: 2-3個工作天內
價格
Back to Top
消化管支架市場分析:產品(膽管、十二指腸、大腸、胰管、食道支架)、用途(肝疾病、大腸癌、胃癌)、各地區的預測 Gastrointestinal (GI) Stents Market Analysis By Product (Biliary, Duodenal, Colonic, Pancreatic, Esophageal Stents), By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer), And Segment Forecasts, 2014 - 2025
出版日期: 2017年08月24日內容資訊: 英文 90 Pages
簡介

本報告提供消化管支架的全球市場調查,整體市場趨勢,各產品、用途、地區的詳細趨勢,市場規模的變化與預測,市場的推動要素及阻礙因素分析,競爭情形,主要企業簡介等總括性彙整。

第1章 調查手法

第2章 摘要整理

第3章 市場趨勢

  • 市場區隔
  • 市場規模與成長率預測
    • 推動因素分析
    • 阻礙因素分析
  • 市場機會
  • 波特的五力分析
  • PESTEL分析

第4章 消化管支架市場:各產品

  • 各產品的市場趨勢分析
  • 膽管支架
  • 十二指腸支架
  • 大腸支架
  • 胰管支架
  • 食道支架

第5章 消化管支架市場:各用途

  • 各用途的市場趨勢分析
  • 肝疾病
  • 大腸癌
  • 胃癌
  • 其他

第6章 消化管支架市場:各地區

  • 各地區的市場趨勢分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
  • 亞太地區
    • 中國
    • 日本
  • 南美
    • 巴西
    • 墨西哥
  • 中東、非洲
    • 南非

第7章 競爭情形

  • 策略架構
  • 企業簡介
目錄
Product Code: GVR-1-68038-883-1

The global gastrointestinal stents (GI stents) market is expected to reach USD 472.5 million by 2025, according to a new report by Grand View Research, Inc. Increasing burden of gastrointestinal diseases including biliary diseases, esophageal cancer, and colorectal cancer are anticipated to boost the usage of GI stents across the globe.

Individuals above 60 years of age form the key target population for these products, as they are at a high risk of developing gastrointestinal and stomach-related diseases. Thus, aging demographics of most of the economies around the globe is a prime factor driving the growth of the sector. Moreover, reimbursement coverage provided by the Center for Medicare & Medicaid Services (CMS) and various private payers is spurring the adoption of GI stents.

Further key findings from the report suggest:

  • The market study suggests that biliary stent dominated the overall sector in 2016. Incidences of biliary diseases such as bile duct cancer, gallstone disease and primary biliary cholangitis are on the rise globally, which would drive the growth of biliary stents sector positively.
  • Esophageal stent segment is expected to witness highest growth rate, owing to development of self-expanding plastic stents and self-expanding metal stents, which have proved to be safe and cost-effective for esophageal pathologies.
  • Approximately, 50?% to 75?% of patients who are primarily treated with endoscopic balloon dilation experience recurrence of the structure within 1 year. Such patients are treated with self-expanding metal stents, thereby driving the growth of the market segment.
  • North America occupied the largest revenue share in 2016, due to the high rate of diagnosing new cases of gastrointestinal diseases and constantly rising awareness regarding commercial availability of effective treatments.
  • In addition, increasing incidences of irritable bowel syndrome, colorectal cancer and pancreatic cancer are a few high impact-rendering drivers for the market
  • Asia Pacific is expected to witness a significant growth during the forecast period. The presence of countries such as Japan, China and India with constantly increasing patient population is a key factor anticipated to fuel the market growth in the region.

Some of the major companies operating in this market are Boston Scientific, Cook Medical, ELLA-CS, s.r.o., ConMed, Gore Medical, TaeWoong Medical, Hobbs Medical, Inc., C.R. Bard, Merit Endotek, Olympus America and others.

Table of Content

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis
  • 1.3 Approaches for Market Estimation
    • 1.3.1 Approach 1: Demand analysis &bottom-up approach
    • 1.3.2 Approach 2: Top-down market estimation
    • 1.3.3 Approach 3: Commodity flow and bottom-up market estimation
    • 1.3.4 Approach 4: KoL perspective-based market sizing

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Gastrointestinal stents Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Market Size and Growth Prospects
    • 3.2.1 Market driver analysis
    • 3.2.2 Market restraint analysis
  • 3.3 Key Opportunities Prioritized
  • 3.4 Industry Analysis Porter's
  • 3.5 PESTEL Analysis

Chapter 4 Gastrointestinal stents Market: Product Estimates & Trend Analysis

  • 4.1 Gastrointestinal stents Market: Product Movement Analysis, 2016 & 2025
  • 4.2 Biliary Stent
    • 4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.3 Duodenal Stent
    • 4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.4 Colonic Stent
    • 4.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.5 Pancreatic Stent
    • 4.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.6 Esophageal Stent
    • 4.6.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5 Gastrointestinal stents Market: Application Estimates & Trend Analysis

  • 5.1 Gastrointestinal stents Market: Application Analysis, 2016 & 2025
  • 5.2 Biliary Disease
    • 5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.3 Colorectal Cancer
    • 5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.4 Stomach Cancer
    • 5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.5 Others
    • 5.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 6 Gastrointestinal stents Market: Regional Estimates & Trend Analysis, by Product & Application

  • 6.1 Gastrointestinal stents Market Share by Region, 2016 & 2025
  • 6.2 North America
    • 6.2.1 U.S.
      • 6.2.1.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.2.1.2 Market estimates and forecasts, by application 2014 - 2025
    • 6.2.2 Canada
      • 6.2.2.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.2.2.2 Market estimates and forecasts, by application 2014 - 2025
  • 6.3 Europe
    • 6.3.1 UK
      • 6.3.1.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.3.1.2 Market estimates and forecasts, by application 2014 - 2025
    • 6.3.2 Germany
      • 6.3.2.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.3.2.2 Market estimates and forecasts, by application 2014 - 2025
  • 6.4 Asia Pacific
    • 6.4.1 China
      • 6.4.1.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.4.1.2 Market estimates and forecasts, by application 2014 - 2025
    • 6.4.2 Japan
      • 6.4.2.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.4.2.2 Market estimates and forecasts, by application 2014 - 2025
  • 6.5 Latin America
    • 6.5.1 Brazil
      • 6.5.1.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.5.1.2 Market estimates and forecasts, by application 2014 - 2025
    • 6.5.2 Mexico
      • 6.5.2.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.5.2.2 Market estimates and forecasts, by application 2014 - 2025
  • 6.6 MEA
    • 6.6.1 South Africa
      • 6.6.1.1 Market estimates and forecasts, by product 2014 - 2025
      • 6.6.1.2 Market estimates and forecasts, by application 2014 - 2025

Chapter 7 Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Company Profiles
    • 7.2.1 Boston Scientific
      • 7.2.1.1 Company overview
      • 7.2.1.2 Financial performance
      • 7.2.1.3 Product benchmarking
      • 7.2.1.4 Strategic initiatives
    • 7.2.2 Cook Medical
      • 7.2.2.1 Company overview
      • 7.2.2.2 Financial performance
      • 7.2.2.3 Product benchmarking
      • 7.2.2.4 Strategic initiatives
    • 7.2.3 ELLA-CS, s.r.o.
      • 7.2.3.1 Company overview
      • 7.2.3.2 Financial performance
      • 7.2.3.3 Product benchmarking
      • 7.2.3.4 Strategic initiatives
    • 7.2.4 ConMed
      • 7.2.4.1 Company overview
      • 7.2.4.2 Financial performance
      • 7.2.4.3 Product benchmarking
      • 7.2.4.4 Strategic initiatives
    • 7.2.5 Gore Medical
      • 7.2.5.1 Company overview
      • 7.2.5.2 Financial performance
      • 7.2.5.3 Product benchmarking
      • 7.2.5.4 Strategic initiatives
    • 7.2.6 Taewoong Medical
      • 7.2.6.1 Company overview
      • 7.2.6.2 Financial performance
      • 7.2.6.3 Product benchmarking
      • 7.2.6.4 Strategic initiatives
    • 7.2.7 Hobbs Medical, Inc.
      • 7.2.7.1 Company overview
      • 7.2.7.2 Financial performance
      • 7.2.7.3 Product benchmarking
      • 7.2.7.4 Strategic initiatives
    • 7.2.8 C.R. Bard
      • 7.2.8.1 Company overview
      • 7.2.8.2 Financial performance
      • 7.2.8.3 Product benchmarking
      • 7.2.8.4 Strategic initiatives
    • 7.2.9 Merit Endotek
      • 7.2.9.1 Company overview
      • 7.2.9.2 Financial performance
      • 7.2.9.3 Product benchmarking
      • 7.2.9.4 Strategic initiatives
    • 7.2.10 Olympus America
      • 7.2.10.1 Company overview
      • 7.2.10.2 Financial performance
      • 7.2.10.3 Product benchmarking
      • 7.2.10.4 Strategic initiatives

List of Tables

  • TABLE 1 Gastrointestinal stents market - industry snapshot
  • TABLE 2 Gastrointestinal stents market, by product, 2014 - 2025 (USD Million)
  • TABLE 3 Gastrointestinal stents market, by application, 2014 - 2025 (USD Million)
  • TABLE 4 Gastrointestinal stents market, by region, 2014 - 2025 (USD Million)
  • TABLE 5 Gastrointestinal stents market: Key market driver analysis
  • TABLE 6 Gastrointestinal stents market: Key market restraint analysis
  • TABLE 7 North America market, by product 2014 - 2025 (USD Million)
  • TABLE 8 North America market, by application 2014 - 2025 (USD Million)
  • TABLE 9 U.S. market, by product 2014 - 2025 (USD Million)
  • TABLE 10 U.S. market, by application 2014 - 2025 (USD Million)
  • TABLE 11 Canada market, by product 2014 - 2025 (USD Million)
  • TABLE 12 Canada market, by application2014 - 2025 (USD Million)
  • TABLE 13 Europe market, by product 2014 - 2025 (USD Million)
  • TABLE 14 Europe market, by application2014 - 2025 (USD Million)
  • TABLE 15 UK market, by product 2014 - 2025 (USD Million)
  • TABLE 16 UK market, by application 2014 - 2025 (USD Million)
  • TABLE 17 Germany market, by product 2014 - 2025 (USD Million)
  • TABLE 18 Germany market, by application 2014 - 2025 (USD Million)
  • TABLE 19 Asia Pacific market, by product 2014 - 2025 (USD Million)
  • TABLE 20 Asia Pacific market, by application 2014 - 2025 (USD Million)
  • TABLE 21 Japan market, by product 2014 - 2025 (USD Million)
  • TABLE 22 Japan market, by application 2014 - 2025 (USD Million)
  • TABLE 23 China market, by product 2014 - 2025 (USD Million)
  • TABLE 24 China market, by application 2014 - 2025 (USD Million)
  • TABLE 25 Latin America market, by product 2014 - 2025 (USD Million)
  • TABLE 26 Latin America market, by application 2014 - 2025 (USD Million)
  • TABLE 27 Brazil market, by product 2014 - 2025 (USD Million)
  • TABLE 28 Brazil market, by application 2014 - 2025 (USD Million)
  • TABLE 29 Mexico market, by product 2014 - 2025 (USD Million)
  • TABLE 30 Mexico market, by application 2014 - 2025 (USD Million)
  • TABLE 31 MEA market, by product 2014 - 2025 (USD Million)
  • TABLE 32 MEA market, by application 2014 - 2025 (USD Million)
  • TABLE 33 South Africa market, by product 2014 - 2025 (USD Million)
  • TABLE 34 South Africa market, by application 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Global Gastrointestinal stents: Market segmentation
  • FIG. 2 Global Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 3 Gastrointestinal stents: Market dynamics
  • FIG. 4 Gastrointestinal stents market: Porter's analysis
  • FIG. 5 Key opportunities prioritized
  • FIG. 6 Gastrointestinal stents market: PESTEL analysis
  • FIG. 7 Gastrointestinal stents market share, by product, 2015 & 2025
  • FIG. 8 Biliary stent market, 2014 - 2025 (USD Million)
  • FIG. 9 Duodenal stent market, 2014 - 2025 (USD Million)
  • FIG. 10 Colonic stent market, 2014 - 2025 (USD Million)
  • FIG. 11 Pancreatic stent market, 2014 - 2025 (USD Million)
  • FIG. 12 Esophageal stent market, 2014 - 2025 (USD Million)
  • FIG. 13 Gastrointestinal stents market share, by application, 2015 & 2024
  • FIG. 14 Biliary Disease market, 2014 - 2025 (USD Million)
  • FIG. 15 Colorectal cancer market, 2014 - 2025 (USD Million)
  • FIG. 16 Stomach cancer market, 2014 - 2025 (USD Million)
  • FIG. 17 Others market, 2014 - 2025 (USD Million)
  • FIG. 18 Gastrointestinal stents market share, by region, 2015 & 2025
  • FIG. 19 North America Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 20 U.S. Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 21 Canada Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 22 Europe Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 23 UK Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 24 Germany Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 25 Asia Pacific Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 26 Japan Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 27 China Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 28 Latin America Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 29 Brazil Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 30 Mexico Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 31 MEA Gastrointestinal stents market, 2014 - 2025 (USD Million)
  • FIG. 32 South Africa Gastrointestinal stents market, 2014 - 2025 (USD Million)
Back to Top